GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,402.50p
   
  • Change Today:
    -32.50p
  • 52 Week High: 1,671.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,092.50m
  • Volume: 24,023,531
  • Market Cap: £57,397m
  • RiskGrade: 129

Latest Deals

Traded Action Notifier PriceAmountValue
10-Jun-25 Transfer From Julie Brown 0.000p 8 £0.00
10-Jun-25 Buy Julie Brown 1,265.04p 8 £101.20
10-Jun-25 Transfer From Emma Walmsley 0.000p 9 £0.00
10-Jun-25 Buy Emma Walmsley 1,265.04p 9 £113.85

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
10-Jun-25 Buy Emma Walmsley 1,265.04p 9 £113.85
10-Jun-25 Buy Julie Brown 1,265.04p 8 £101.20
10-Jun-25 Transfer From Julie Brown 0.000p 8 £0.00
10-Jun-25 Transfer From Emma Walmsley 0.000p 9 £0.00

Director Shareholdings

Notifier Holding Value*
Vishal Sikka 253,472,390 £3,554,950,270
Hal Barron 6,654,928 £93,335,365
Emma Walmsley 2,903,192 £40,717,268
Jonathan Symonds 66,543 £933,266
Charles Bancroft 56,221 £788,500
Julie Brown 44,359 £622,135
Anne Beal 6,447 £90,419
Harry (Hal) C. Dietz 5,080 £71,247
Elizabeth (Liz) McKee Anderson 3,688 £51,724
Jeannie Lee 2,054 £28,807
Wendy Becker 1,991 £27,924

Major Shareholders

Notifier** Holding Value*
Dodge & Cox 253,464,108 £3,554,834,115
Dodge & Cox 253,464,108 £3,554,834,115
BlackRock Inc 231,975,400 £3,253,454,985
GSK plc 197,068,169 £2,763,881,070
The Capital Group Companies, Inc. 159,068,073 £2,230,929,724
Legal & General Group Plc 95,878,187 £1,344,691,573

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,402.50p
Change Today -32.50p
% Change -2.26 %
52 Week High 1,671.00
52 Week Low 1,264.00
Volume 24,023,531
Shares Issued 4,092.50m
Market Cap £57,397m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.79% below the market average47.79% below the market average47.79% below the market average47.79% below the market average47.79% below the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Trend
7.48% above the market average7.48% above the market average7.48% above the market average7.48% above the market average7.48% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Income
73.31% above the market average73.31% above the market average73.31% above the market average73.31% above the market average73.31% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
33.33% below the market average33.33% below the market average33.33% below the market average33.33% below the market average33.33% below the market average
41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 20-Jun-2025

Time Volume / Share Price
15:51 0 @ 1,403.50p
15:51 1 @ 1,403.50p
15:51 0 @ 1,403.50p
15:43 1 @ 1,400.00p
15:51 1 @ 1,403.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page